MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 48 filers reported holding MEI PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,148 | -14.2% | 21,132 | +41.9% | 0.00% | – |
| Q3 2022 | $6,000 | -91.3% | 14,887 | -87.0% | 0.00% | – |
| Q2 2022 | $69,000 | -55.2% | 114,122 | -55.4% | 0.00% | – |
| Q1 2022 | $154,000 | -75.4% | 255,594 | +8.9% | 0.00% | – |
| Q4 2021 | $627,000 | -21.7% | 234,776 | -19.1% | 0.00% | – |
| Q3 2021 | $801,000 | -40.1% | 290,201 | -38.2% | 0.00% | – |
| Q2 2021 | $1,338,000 | -52.6% | 469,246 | -42.9% | 0.00% | -100.0% |
| Q1 2021 | $2,821,000 | +142.8% | 822,225 | +86.7% | 0.00% | – |
| Q4 2020 | $1,162,000 | -11.7% | 440,404 | +4.4% | 0.00% | – |
| Q3 2020 | $1,316,000 | -5.8% | 421,936 | +24.7% | 0.00% | – |
| Q2 2020 | $1,397,000 | +721.8% | 338,252 | +221.3% | 0.00% | – |
| Q1 2020 | $170,000 | +24.1% | 105,265 | +90.3% | 0.00% | – |
| Q4 2019 | $137,000 | +101.5% | 55,325 | +36.8% | 0.00% | – |
| Q3 2019 | $68,000 | -75.3% | 40,433 | -63.3% | 0.00% | – |
| Q2 2019 | $275,000 | -60.0% | 110,084 | -50.9% | 0.00% | – |
| Q1 2019 | $688,000 | +189.1% | 224,147 | +270.5% | 0.00% | – |
| Q2 2018 | $238,000 | +561.1% | 60,493 | +248.3% | 0.00% | – |
| Q1 2018 | $36,000 | -37.9% | 17,367 | -37.1% | 0.00% | – |
| Q4 2017 | $58,000 | -64.0% | 27,629 | -58.9% | 0.00% | – |
| Q2 2017 | $161,000 | +22.9% | 67,209 | -16.6% | 0.00% | – |
| Q1 2017 | $131,000 | +162.0% | 80,570 | +131.7% | 0.00% | – |
| Q4 2016 | $50,000 | -45.1% | 34,777 | -32.4% | 0.00% | – |
| Q3 2016 | $91,000 | +193.5% | 51,429 | +119.8% | 0.00% | – |
| Q2 2016 | $31,000 | +10.7% | 23,399 | +4.6% | 0.00% | – |
| Q1 2016 | $28,000 | -37.8% | 22,364 | -20.7% | 0.00% | – |
| Q4 2015 | $45,000 | -66.7% | 28,209 | -67.2% | 0.00% | – |
| Q3 2015 | $135,000 | -61.4% | 85,923 | -57.9% | 0.00% | – |
| Q2 2015 | $350,000 | -9.6% | 204,323 | -5.3% | 0.00% | – |
| Q1 2015 | $387,000 | +90.6% | 215,789 | +354.1% | 0.00% | – |
| Q4 2014 | $203,000 | -52.6% | 47,515 | -23.4% | 0.00% | – |
| Q3 2014 | $428,000 | +205.7% | 62,045 | +180.5% | 0.00% | – |
| Q2 2014 | $140,000 | -58.7% | 22,119 | -27.4% | 0.00% | – |
| Q1 2014 | $339,000 | +28.4% | 30,449 | -7.8% | 0.00% | – |
| Q4 2013 | $264,000 | – | 33,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 4,610,423 | $1,782,000 | 0.21% |
| DAFNA Capital Management LLC | 1,767,146 | $683,000 | 0.18% |
| NEA Management Company, LLC | 8,533,072 | $3,299,000 | 0.16% |
| Boxer Capital, LLC | 2,913,091 | $1,126,000 | 0.06% |
| BVF INC/IL | 3,532,057 | $1,365,000 | 0.06% |
| Investmark Advisory Group LLC | 136,000 | $52,000 | 0.05% |
| CARLSON CAPITAL L P | 1,150,000 | $445,000 | 0.03% |
| Artal Group S.A. | 1,000,000 | $387,000 | 0.02% |
| Annandale Capital, LLC | 100,000 | $39,000 | 0.01% |
| Sigma Planning Corp | 641,050 | $248,000 | 0.01% |